Pricing Log in Create free account
Friday 6 November 2026 Export SNN’s income statement to Excel — free account

Smith & Nephew SNATS, Inc.

SNN Healthcare Medical Devices

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.12 0.89 −2.78%
Market cap
$13.4B
P/E
38.9×
Fwd P/E
18.9×
Dividend yield
2.49%
F-score
7/9
Altman Z
3.49
Beneish M
−2.70
Dividend safety
61/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Smith & Nephew SNATS, Inc. (SNN) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Smith & Nephew SNATS, Inc. (SNN) trades at a EV/EBITDA of 6.5×. Over the past ten years it has ranged from 4.4× (September 2022) to 16.0× (April 2018); the current reading is higher than 31% of that period. That is below the Medical Devices industry median of 11.5× and below the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 6.7× 26.89%
FY2024 5.3× (2.83%)
FY2023 5.5× (2.26%)
FY2022 5.6× (22.36%)
FY2021 7.2× (16.65%)
FY2020 8.7× (11.83%)
FY2019 9.8× (13.88%)
FY2018 11.4× (20.06%)
FY2017 14.3× 13.36%
FY2016 12.6× (13.70%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2023 6.6× 19.02%
Dec 2022 5.5× (0.98%)
Jun 2022 5.6× (23.43%)
Dec 2021 7.3× (18.20%)
6 more quarters

Against its own ten years

Low 4.4× High 16.0×
Ten-year median 8.5×
Current reading's percentile 31

EV/EBITDA against peers

Company EV/EBITDA
BIO Bio-Rad Laboratories, Inc. compare n/m
GKOS Glaukos Corporation compare n/m
TXG 10x Genomics compare n/m
BIO.B Bio-Rad Laboratories, Inc. compare n/m
SNN Smith & Nephew SNATS, Inc. 6.5×
GMED Globus Medical, Inc. compare 11.9×
PODD Insulet Corporation compare 16.1×
PEN Penumbra, Inc. compare 57.3×
BRKR Bruker Corporation compare 66.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SNN